Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2000 Mar 7;39(2):261–276. doi: 10.1016/0168-1702(95)00100-X

A conditional-lethal murine coronavirus mutant that fails to incorporate the spike glycoprotein into assembled virions

Cynthia S Ricard a,1, Cheri A Koetzner b, Lawrence S Sturman b,c, Paul S Masters b,c,*
PMCID: PMC7134215  PMID: 8837889

Abstract

The coronavirus spike glycoprotein (S) mediates both the attachment of virus to the host cell receptor and membrane fusion. We describe here the characterization of a temperature-sensitive mutant of the coronavirus mouse hepatitis virus A59 (MHV-A59) having multiple S protein-related defects. The most remarkable of these was that the mutant, designated Albany 18 (Alb 18), assembled virions devoid of the S glycoprotein at the nonpermissive temperature. Alb18 also failed to bring about syncytia formation in cells infected at the nonpermissive temperature. Virions of the mutant assembled at the permissive temperature were much more thermolabile than wild type. Moreover, mutant S protein that was incorporated into virions at the permissive temperature showed enhanced pH-dependent thermolability in its ability to bind to the MHV receptor. Alb18 was found to have a single point mutation in S resulting in a change of serine 287 to isoleucine, and it was shown by revertant analysis that this was the lesion responsible for the phenotype of the mutant.

Keywords: Coronavirus, Spike glycoprotein, Temperature-sensitive mutant, Virus assembly

Reference

  1. Boyle J.F., Weismiller D.G., Holmes K.V. Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues. J. Virol. 1987;61:185–189. doi: 10.1128/jvi.61.1.185-189.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cavanagh D. Coronavirus IBV: structural characterization of the spike protein. J. Gen. Virol. 1983;64:2577–2583. doi: 10.1099/0022-1317-64-12-2577. [DOI] [PubMed] [Google Scholar]
  3. Compton S.R., Barthold S.W., Smith A.L. The cellular and molecular pathogenesis of coronaviruses. Lab. Anim. Sci. 1993;43:15–28. [PubMed] [Google Scholar]
  4. Dea S., Garzon S., Tijssen P. Identification and location of the structural glycoproteins of a tissue culture-adapted turkey enteric coronavirus. Arch. Virol. 1989;106:221–237. doi: 10.1007/BF01313955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Delmas B., Laude H. Assembly of coronavirus spike protein into trimers and its role in epitope expression. J. Virol. 1990;64:5367–5375. doi: 10.1128/jvi.64.11.5367-5375.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Frana M.F., Behnke J.N., Sturman L.S., Holmes K.V. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion. J. Virol. 1985;56:912–920. doi: 10.1128/jvi.56.3.912-920.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fu K., Baric R.S. Map locations of mouse hepatitis virus temperature-sensitive mutants: confirmation of variable rates of recombination. J. Virol. 1994;68:7458–7466. doi: 10.1128/jvi.68.11.7458-7466.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gallagher T.M., Parker S.E., Buchmeier M.J. Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein. J. Virol. 1990;64:731–741. doi: 10.1128/jvi.64.2.731-741.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gallagher T.M., Escarmis C., Buchmeier M.J. Alteration of the pH dependence of coronavirus-induced cell-fusion: effect of mutations in the spike glycoprotein. J. Virol. 1991;65:1916–1928. doi: 10.1128/jvi.65.4.1916-1928.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gallione C.J., Rose J.K. A single amino acid substitution in a hydrophobic domain causes temperature-sensitive cell-surface transport of a mutant viral glycoprotein. J. Virol. 1985;54:374–382. doi: 10.1128/jvi.54.2.374-382.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gombold J.L., Hingley S.T., Weiss S.R. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 1993;67:4504–4512. doi: 10.1128/jvi.67.8.4504-4512.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gubler U., Hoffman B.J. A simple and very efficient method for generating cDNA libraries. Gene. 1983;25:263–269. doi: 10.1016/0378-1119(83)90230-5. [DOI] [PubMed] [Google Scholar]
  13. Holmes K.V., Doller E.W., Sturman L.S. Tunicamycin resistant glycosylation of a coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein. Virology. 1981;115:334–344. doi: 10.1016/0042-6822(81)90115-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Koetzner C.A., Parker M.M., Ricard C.S., Sturman L.S., Masters P.S. Repair and mutagenesis of the genome of a deletion mutant of the coronavirus mouse hepatitis virus by targeted RNA recombination. J. Virol. 1992;66:1841–1848. doi: 10.1128/jvi.66.4.1841-1848.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kubo H., Yamada Y.K., Taguchi F. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol. 1994;68:5403–5410. doi: 10.1128/jvi.68.9.5403-5410.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kusters J.G., Niesters H.G.M., Lenstra J.A., Horzinek M.C., van der Zeijst B.A.M. Phylogeny of antigenic variants of avian coronavirus IBV. Virology. 1989;169:217–221. doi: 10.1016/0042-6822(89)90058-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacterioshage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  18. La Monica N., Banner L.R., Morris V.L., Lai M.M.C. Localization of extensive deletions in the structural genes of two neurotropic variants of murine coronavirus JHM. Virology. 1991;182:883–888. doi: 10.1016/0042-6822(91)90635-O. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Luytjes W., Sturman L.S., Bredenbeek P.J., Charite J., van der Zeijst B.A.M., Horzinek M.C., Spaan W.J.M. Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology. 1987;161:479–487. doi: 10.1016/0042-6822(87)90142-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Luytjes W., Bredenbeek P.J., Noten A.F.H., Horzinek M.C., Spaan W.J.M. Sequence of mouse hepatitis virus A59 mRNA2: Indications for RNA recombination between coronaviruses and influenza C virus. Virology. 1988;166:415–422. doi: 10.1016/0042-6822(88)90512-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Masters P.S., Koetzner C.A., Kerr C.A., Heo Y. Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus. J. Virol. 1994;68:328–337. doi: 10.1128/jvi.68.1.328-337.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Metsikkö K., Simons K. The budding mechanism of spikeless vesicular stomatitis virus particles. EMBO J. 1986;5:1913–1920. doi: 10.1002/j.1460-2075.1986.tb04444.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mounir S., Talbot P.J. Sequence analysis of the membrane protein gene of human coronavirus OC43 and evidence for O-glycosylation. J. Gen. Virol. 1992;73:2731–2736. doi: 10.1099/0022-1317-73-10-2731. [DOI] [PubMed] [Google Scholar]
  24. Opstelten D.-J.E., de Groote P., Horzinek M.C., Vennema H., Rottier P.J.M. Disulfide bonds in folding and transport of mouse hepatitis coronavirus glycoproteins. J. Virol. 1993;67:7394–7401. doi: 10.1128/jvi.67.12.7394-7401.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Parker S.E., Gallagher T.M., Buchmeier M.J. Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology. 1989;173:664–673. doi: 10.1016/0042-6822(89)90579-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ricard C.S., Sturman L.S. Isolation of the subunits of the coronavirus envelope glycoprotein E2 by hydroxyapatite high performance liquid chromatography. J. Chromatogr. 1985;326:191–197. doi: 10.1016/S0021-9673(01)87445-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rottier P.J.M., Horzinek M.C., van der Zeijst B.A.M. Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effects of tunicamycin. J. Virol. 1981;40:350–357. doi: 10.1128/jvi.40.2.350-357.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sanger F., Nicklen S., Coulson A.R. Vol. 74. 1977. DNA sequencing with chain terminating inhbitors; pp. 5463–5467. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sturman L.S. Characterization of a coronavirus: I. Structural proteins: effect of preparative conditions on the migration of protein in polyacrylamide gels. Virology. 1977;77:637–649. doi: 10.1016/0042-6822(77)90488-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sturman L.S., Holmes K.V. The molecular biology of coronaviruses. Adv. Virus Res. 1983;28:35–111. doi: 10.1016/S0065-3527(08)60721-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sturman L.S., Holmes K.V. The novel glycoproteins of coronaviruses. Trends Biochem. Sci. 1985;10:17–20. [Google Scholar]
  32. Sturman L.S., Holmes K.V., Behnke J. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J. Virol. 1980;33:449–462. doi: 10.1128/jvi.33.1.449-462.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sturman L.S., Ricard C.S., Holmes K.V. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Activation of cell-fusing activity of virions by trypsin and separation of two different 90 K cleavage fragments. J. Virol. 1985;56:904–911. doi: 10.1128/jvi.56.3.904-911.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sturman L.S., Eastwood C., Frana M.F., Duchala C., Baker F., Ricard C.S., Sawicki S.G., Holmes K.V. Temperature-sensitive mutants of MHV-A59. In: Lai M.M.C., Stohlman S.A., editors. Coronaviruses. Plenum Press; New York: 1987. pp. 159–168. [DOI] [PubMed] [Google Scholar]
  35. Sturman L.S., Ricard C.S., Holmes K.V. Conformational change of the coronavirus peplomer glycoprotein E2 at pH 8.0 correlates with virus aggregation and virus-induced cell fusion. J. Virol. 1990;64:3042–3050. doi: 10.1128/jvi.64.6.3042-3050.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tooze J., Tooze S.A. Infection of AtT20 murine pituitary tumor cells by mouse hepatitis virus strain A59: virus budding is restricted to the Golgi region. Eur. J. Cell Biol. 1985;37:203–212. [PubMed] [Google Scholar]
  37. Tooze J., Tooze S.A., Warren G. Replication of coronavirus MHV-A59 in Sac− cells: determination of the first site of budding of progeny virions. Eur. J. Cell Biol. 1984;33:281–293. [PubMed] [Google Scholar]
  38. Vennema H., Rottier P.J.M., Heijnen L., Godeke G.J., Horzinek M.C., Spaan W.J.M. Biosynthesis and function of the coronavirus spike protein. In: Cavanagh D., Brown T.D.K., editors. Coronaviruses and Their Diseases. Plenum Press; New York: 1990. pp. 9–19. [DOI] [PubMed] [Google Scholar]
  39. Wang F.-I., Fleming J.O., Lai M.M.C. Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity. Virology. 1992;186:742–749. doi: 10.1016/0042-6822(92)90041-M. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Williams R.W., Jiang G.-S., Snyder S.W., Frana M.F., Holmes K.V. Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice. J. Virol. 1990;64:3817–3823. doi: 10.1128/jvi.64.8.3817-3823.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Williams R.W., Jiang G.-S., Holmes K.V. Vol. 88. 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins; pp. 5533–5536. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Yu X., Bi W., Weiss S.R., Leibowitz J.L. Mouse hepatitis virus gene 5b protein is a new virion envelope protein. Virology. 1994;202:1018–1023. doi: 10.1006/viro.1994.1430. [DOI] [PubMed] [Google Scholar]

Articles from Virus Research are provided here courtesy of Elsevier

RESOURCES